scorecardresearch
Friday, April 26, 2024
TopicJ&J

Topic: J&J

J&J’s new flu drug flop shows how difficult it is to fight viruses

Johnson & Johnson stopped developing the drug pimodivir in the final stage of testing it for patients with influenza A, the most common cause of flu, after a study indicated it won't work.

Hip implants dent brand Johnson & Johnson, patients begin questioning other devices

Doctors say Johnson & Johnson's hip implant controversy is causing concern among Indian patients fitted with other devices from the company.

On Camera

Why the future of cars does not look electrified

Making a jump from internal combustion engines to electric vehicles is the kind of romantic prospect that would appeal to India, which jumped from a shortage of landline phones to an abundance of smartphones.

Notices, fines, court case & now a limited ban — RBI-Kotak relationship has been fraught for years

RBI Wednesday banned Kotak Mahindra Bank from taking on new customers through digital channels & from issuing new credit cards. Violations had to do with strength of bank’s IT infra.

Rafale to Exercise Garuda, a look at Indo-French defence ties as Chief of Defence Staff visits France

Another addition to military cooperation has been the Strategic Space Dialogue, inaugurated in Paris in 2023. Last month, India participated as an observer to France’s AsterX.

These 6 states are key for Modi’s ‘400 paar’ target. They’re also where Opposition can stop him

While this contest looks so predictable in large swathes of our political landscape, it is also more keenly contested than 2019 in some states.